Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia

Effect of Ceftobiprole on Human Intestinal Microflora

NCT00965042 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia

NCT01701219 ·Status: COMPLETED ·Phase: PHASE4

Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia

NCT03163446 ·Status: COMPLETED ·Phase: PHASE2

Cefazolin Versus Antistaphylococcal Penicillins for Methicillin Susceptible Staphylococcus Aureus Bacteremia

NCT07186894 ·Status: ACTIVE_NOT_RECRUITING

Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers

NCT01026740 ·Status: COMPLETED ·Phase: PHASE1

Seven Versus Fourteen Days of Treatment in Uncomplicated Staphylococcus Aureus Bacteremia

NCT03514446 ·Status: UNKNOWN ·Phase: PHASE4

A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects

NCT02439359 ·Status: COMPLETED ·Phase: PHASE1

A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age

NCT01026636 ·Status: COMPLETED ·Phase: PHASE1

Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 - 17 Year Olds With Staphylococcus Aureus Bacteremia (MK-3009-005)

NCT01728376 ·Status: COMPLETED ·Phase: PHASE4

Antistaphylococcal Betalactam and Emergence of Resistance

NCT05939479 ·Status: COMPLETED

Ceftriaxone as Home IV for Staph Infections

NCT04141787 ·Status: UNKNOWN ·Phase: PHASE4

Safety and Efficacy Study of CUBICIN (Daptomycin) Under Conditions of Actual Use

NCT01219114 ·Status: WITHDRAWN

Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections

NCT03137173 ·Status: COMPLETED ·Phase: PHASE3

A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection

NCT06966284 ·Status: RECRUITING

Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia

NCT04886284 ·Status: RECRUITING ·Phase: PHASE2

Assessment of the Safety and Efficacy of Ciproxan-I.V. in Daily Clinical Practice - Analysis Results From a Post-marketing Surveillance

NCT01670435 ·Status: COMPLETED

Staphylococcus Aureus Bacteremia Antibiotic Treatment Options

NCT01792804 ·Status: COMPLETED ·Phase: PHASE3

Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections

NCT00427076 ·Status: COMPLETED ·Phase: PHASE3

Subphenotype- and Complication-guided Adjunctive Fosfomycin Therapy for Staphylococcus Aureus Bacteraemia

NCT07155590 ·Status: ACTIVE_NOT_RECRUITING

Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline

NCT01724671 ·Status: UNKNOWN

Clinical Outcomes With Ceftolozane-tazobactam for MDR Pseudomonas Infections

NCT03510351 ·Status: COMPLETED

Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus

NCT01645735 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Nephrotoxicity and Hospital Costs in Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia Who Received Vancomycin Versus Teicoplanin Therapy

NCT01352936 ·Status: UNKNOWN

A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients

NCT01026558 ·Status: COMPLETED ·Phase: PHASE1

Special Drug Use Investigation of Ciproxan Injection in Pediatrics

NCT02555059 ·Status: COMPLETED